Autophagy: your cells’ cleanup crew

LONGEVITY LATEST | The Evidence-Based Edge on Living Longer and Better

LONGEVITY LATEST

Issue 03 | March 2026

The Evidence-Based Edge on Living Longer and Better

Autophagy: your cells’ cleanup crew 🧬

Rapamycin, spermidine, and quercetin graded. Telomere pills debunked. Broccoli sprouts earn their hype. Plus: why your brain can only clean itself while you sleep. 🧬

👋 Welcome to Issue 03

This week, we’re exploring autophagy — the cellular recycling system that clears damaged proteins and dysfunctional organelles from your cells. It declines with age, and restoring it is one of the most exciting frontiers in longevity science. We’ve graded three compounds that target this pathway, put quercetin under the Spotlight as a senolytic, and investigated a £100-per-bottle “telomere lengthening” supplement that may not deserve your money.

In this issue:

Top 3: Rapamycin, spermidine, and quercetin — graded for autophagy

Spotlight: Quercetin as a senolytic — can it clear zombie cells?

Hype Check: TA-65 telomere supplement vs. the £100 price tag

Superfood: Broccoli sprouts and sulforaphane

Deep Dive: Autophagy — the cellular recycling system

Biohacking: Sleep and the glymphatic brain cleanup system

🔬 Top 3 Interventions Under the Microscope

1. Rapamycin (mTOR Inhibitor)

Evidence Grade: C — Strong pre-clinical, insufficient human data

What it is. Rapamycin inhibits mTOR, a nutrient-sensing kinase that regulates cell growth and autophagy. When mTOR is chronically active, autophagy is suppressed and cells accumulate damage. Rapamycin dials it down, engaging the cell’s recycling machinery.

Evidence (animal/pre-clinical). The most replicated lifespan-extending compound in mice. The NIA’s Intervention Testing Program consistently shows it extends median and maximum lifespan in both sexes. A 2025 Nature Aging study combining rapamycin with trametinib produced a 30% lifespan increase in mice (Gkioni et al., 2025).

Human evidence. The PEARL trial (n=150) found low-dose intermittent rapamycin well-tolerated over one year with modest biomarker changes. An Oxford pilot study (Kell et al., 2025, preprint) reported that 8 weeks of 1 mg/day reduced the senescence marker p21 in immune cells. However, a 2025 systematic review in Aging concluded that fewer than a dozen human trials exist, and none has demonstrated that rapamycin extends healthspan or lifespan in healthy adults.

Cautions. Mouth ulcers, impaired wound healing, insulin resistance, increased infection risk. Interacts with CYP3A4 substrates and CBD. May paradoxically support tumour survival via enhanced autophagy in established cancers.

Takeaway. The most robust animal longevity data of any compound, but a potent immunosuppressant with real side effects. Not for self-experimentation. Evidence Grade C.

2. Spermidine (Natural Polyamine)

Evidence Grade: B — Promising human data

What it is. Spermidine is a naturally occurring polyamine found in wheat germ, aged cheese, mushrooms, and soya beans. It activates autophagy by inhibiting the acetyltransferase EP300, which normally suppresses the cell’s recycling machinery. A 2024 study in Nature Cell Biology revealed that spermidine is an essential downstream effector of fasting-mediated autophagy (Hofer et al., 2024). Intracellular levels decline with age.

Evidence (animal/pre-clinical). Spermidine extends lifespan in yeast, flies, worms, and mice. In mice, it has demonstrated cardioprotective and neuroprotective effects, reduced age-related oxidative protein damage, and the longevity benefits require functional autophagy genes — confirming the mechanism.

Human evidence. Two prospective population-based studies (n=1,770, median 13-year follow-up) found higher dietary spermidine independently associated with reduced all-cause, cardiovascular, and cancer-related mortality, even after correcting for age, BMI, diet quality, and physical activity (Kiechl et al., 2018). A small RCT found spermidine improved memory in older adults with subjective cognitive decline. Large-scale RCTs are still lacking.

Cautions. Generally well-tolerated at dietary doses. Long-term safety of chronic supplementation beyond dietary intake has not been fully established. Individuals on immunosuppressive therapy should consult a clinician, as polyamines play roles in immune regulation.

Takeaway. Strong animal data, compelling epidemiological evidence, accessible through diet. One of the more promising autophagy-enhancing interventions. Evidence Grade B.

3. Quercetin (Flavonoid / Senolytic)

Evidence Grade: C — Strong pre-clinical, insufficient human data

What it is. Quercetin is a plant flavonoid found in onions, apples, berries, and capers. It activates autophagy and, when combined with the cancer drug dasatinib (D+Q), acts as a senolytic — selectively eliminating senescent “zombie” cells that drive chronic inflammation through the SASP.

Evidence (animal/pre-clinical). D+Q was the first senolytic combination identified (Zhu et al., 2015). In mice, intermittent D+Q reduced senescent cell burden, improved glucose tolerance, and reduced inflammatory markers. A January 2026 study in eBioMedicine confirmed these effects in diabetic kidney disease models.

Human evidence. A pilot in diabetic kidney disease (n=9) showed D+Q reduced senescent cell markers. A 2025 pilot in older adults with MCI (n=12) found D+Q well-tolerated with cognitive improvement in those with highest senescent cell burdens. However, one DNA methylation study (n=19) found D+Q unexpectedly accelerated some first-generation epigenetic clocks. See the Spotlight below for full analysis.

Cautions. Quercetin alone is well-tolerated. The D+Q combination involves dasatinib, a prescription chemotherapy agent with haematological effects — medical supervision only. Intermittent dosing (two days on, five off) is standard.

Takeaway. Exciting senolytic potential, but human evidence is limited to tiny pilot studies. Quercetin alone is safe; the senolytic effect requires dasatinib and clinical oversight. Evidence Grade C.

🔦 Spotlight Treatment: Quercetin as a Senolytic

We graded quercetin above as a Top 3 intervention. Here, we go deeper on its senolytic potential — the ability to clear senescent “zombie” cells that accumulate with age and drive chronic inflammation through the SASP (senescence-associated secretory phenotype).

Pros:

First senolytic combination validated in peer-reviewed research (Zhu et al., 2015)

Pilot data shows D+Q reduces senescent cell markers in human adipose tissue

Intermittent dosing (2 days on, 5 off) reduces off-target risk

Quercetin alone is inexpensive and safe as a dietary supplement

January 2026 study confirmed senolytic effects in diabetic kidney disease with human cell validation

Cons:

Bottom line: ⏳ Watch this space. Strong rationale, promising early data, but we’re in the earliest phase of human testing. Do not self-administer dasatinib. Quercetin alone is safe but won’t clear senescent cells without its pharmaceutical partner.

🚨 Hype Check: TA-65 Telomere Supplement

The Hype: TA-65, derived from Astragalus membranaceus, is marketed as a “telomerase activator” that lengthens telomeres and slows cellular ageing. A 90-count bottle retails for £100–£600 depending on dose, and the company has described it as “Nobel Prize Technology.” The FTC took action against TA Sciences in 2018 for unsupported health claims.

The Evidence: A 2025 meta-analysis of eight RCTs (n=750) found a moderate increase in leukocyte telomere length with TA-65. However, no significant improvements were found in any functional outcome — no changes in frailty, grip strength, walking speed, or inflammation. A recent RCT found no effect on telomerase activity itself. The likely explanation? TA-65 may shift immune cell populations toward naïve T-cells (which have longer telomeres), inflating the measurement without activating telomerase. In mice, TA-65 did not extend lifespan.

Why It’s Misleading: The marketing conflates a surrogate biomarker (telomere length) with a clinical benefit (slower ageing). A longer measurement means nothing without improved function, health, or survival. Nobel laureate Carol Greider, who won the Prize for telomerase research, has publicly questioned whether TA-65 does what the company claims.

Our Verdict: Skip it. At £100–£600 per bottle, you get a telomere measurement change with no functional benefit and no lifespan extension in any animal model. For telomere maintenance, exercise, a Mediterranean diet, and stress management are free and better supported.

🥦 Superfood Spotlight: Broccoli Sprouts

Broccoli sprouts are among the most nutrient-dense longevity foods, thanks to sulforaphane — an isothiocyanate that activates the Nrf2 antioxidant pathway and stimulates autophagy. Sprouts contain 20–50 times more sulforaphane precursor than mature broccoli.

A 2025 C. elegans study found sulforaphane extended lifespan by over 50% at optimal doses, with treated organisms exhibiting a transcriptional age approximately 20% younger than controls. Multiple meta-analyses of cruciferous vegetables in humans show associations with reduced cancer, cardiovascular, and all-cause mortality.

Key nutrients: Sulforaphane, vitamin C, vitamin K, folate, fibre.

Serving suggestion: Add 30–60 g of raw sprouts to salads or smoothies. Chewing or blending activates the myrosinase enzyme that converts glucoraphanin to sulforaphane. Cooking destroys myrosinase — consume raw or lightly steamed with a pinch of mustard seed powder (which provides exogenous myrosinase).

Caveat: Individuals on blood-thinning medication should monitor vitamin K intake. Start with small servings if you have IBS, as cruciferous vegetables can cause bloating.

🔬 Deep Dive: Autophagy — The Cellular Recycling System

By the time you notice you’re ageing, your cells have been drowning in their own waste for years. Misfolded proteins, damaged mitochondria, and dysfunctional organelles accumulate silently, clogging the machinery that keeps you alive. The process that should clear this debris — autophagy — declines with every passing decade. And when it fails, the downstream consequences read like a catalogue of age-related disease: neurodegeneration, chronic inflammation, metabolic dysfunction, and cancer.

This issue’s three interventions all target this system: rapamycin releases the mTOR brake; spermidine activates autophagy through acetyltransferase inhibition; and fasting triggers a spermidine-dependent cascade. In the full Deep Dive, we unpack how autophagy works at the molecular level, why it declines with age, and which interventions have the strongest evidence for restoration.

🔍 Read the full Deep Dive: Autophagy and the Science of Cellular Renewal → [link]

⚡ Biohacking Corner: Sleep as Autophagy — Your Brain’s Overnight Cleanup

While you sleep, your brain runs a waste-clearance programme that cannot operate effectively during waking hours. The glymphatic system — a network of fluid channels along blood vessels — flushes cerebrospinal fluid through neural tissue during deep sleep, carrying away amyloid-β and tau proteins, the hallmarks of Alzheimer’s disease. A January 2026 crossover trial (n=39, Nature Communications) confirmed it: normal sleep significantly increased overnight clearance of Alzheimer’s biomarkers into plasma compared to sleep deprivation. This is autophagy’s partner system — while cellular autophagy recycles damage inside cells, the glymphatic system clears debris from between them.

Why it matters for ageing: A 2025 Molecular Psychiatry study (n=72 older adults) found poor sleep quality directly impaired glymphatic function, disrupting brain connectivity and memory. The glymphatic system degrades with age, and a Science review described its failure as a potential “final common pathway to dementia.” Sleep is not rest — it is active maintenance.

Three evidence-based sleep strategies for brain autophagy:

Protect deep (slow-wave) sleep. Glymphatic clearance peaks during NREM slow-wave sleep. Alcohol, late caffeine, and sleep fragmentation suppress it disproportionately. Cut caffeine by early afternoon, alcohol by 3 hours before bed, and cool your bedroom to 16–18°C — core temperature must drop to initiate deep sleep.

Sleep 7–9 hours consistently. Sleep deprivation impairs molecular clearance from the brain (Eide et al., Brain, 2021). Regularity matters as much as duration — a consistent sleep-wake schedule supports circadian-driven glymphatic rhythms.

Treat sleep apnoea aggressively. Sleep-disordered breathing fragments slow-wave sleep and is independently associated with impaired glymphatic markers and accelerated amyloid accumulation. If you snore heavily or wake unrefreshed, get assessed — this is the single most underdiagnosed barrier to brain clearance.

Caveat: Persistent sleep difficulties may indicate an underlying sleep disorder. If you regularly sleep fewer than 6 hours despite adequate opportunity, consult a clinician.

📊 Reader Pulse

This week’s question: How do you rate your sleep quality? Reply with your answer: (A) Excellent — 7–9 hours of uninterrupted sleep most nights, (B) Good — but I wake up once or twice, (C) Poor — I regularly sleep fewer than 6 hours or wake frequently, (D) I’ve never tracked it. We’ll share the results in next week’s issue.

👋 See You Next Week

Next week: We’re grading omega-3s, CoQ10, and PQQ — three compounds targeting mitochondrial function. Urolithin A goes under the Spotlight as a mitophagy activator. And the Hype Check tackles a “brain ageing” supplement with heavy podcast advertising and not much data.

Reply with your suggestions. Forward this issue to someone who’d benefit.

Stay curious and stay healthy! — See you in Issue 04!

Medical Disclaimer: Longevity Latest is for educational purposes only and does not constitute medical advice. The information provided is based on publicly available research and does not replace consultation with a qualified healthcare professional. Always consult your doctor before starting any new supplement, medication, or dietary intervention. Some interventions discussed (particularly rapamycin and dasatinib) are prescription medications with significant side effects and should only be used under medical supervision.

© 2026 Longevity Latest Newsletter | For educational purposes only. Not medical advice.